SAN DIEGO--(BUSINESS WIRE)--Mar. 6, 2019--
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery
and diabetes technology company, today announced that John Sheridan,
president and chief executive officer, will present at the following
upcoming investor conferences:
Cowen 39th Annual Healthcare Conference on Tuesday, March
12, 2019 in Boston at 8:00am Eastern Time (5:00am Pacific Time).
- Barclays Global Healthcare Conference on Thursday, March 14, 2019 in
Miami at 8:00am Eastern Time (5:00am Pacific Time).
Oppenheimer 29th Annual Healthcare Conference on Tuesday,
March 19, 2019 in New York at 8:35am Eastern Time (5:35am Pacific
The presentations will be webcast live, and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™
insulin pump, is capable of remote software updates using a personal
computer and features integrated continuous glucose monitoring. Tandem
is based in San Diego, California.
Tandem Diabetes Care is a registered trademark, and t:slim X2 is a
trademark of Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2,
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005806/en/
Source: Tandem Diabetes Care, Inc.